Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 16
- 13F valueReported value at the end of Q2 2026
- $764.1K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding INCR, Q2 2026
No superinvestor reported holding INCR at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Intercure Ltd. insiders from Form 4, newest first.
No open-market purchases or sales by Intercure Ltd. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Intercure Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 212,500 | $325.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 107,913 | $118.7K | 0.00% | −26,006−19.4% | Reduced |
| Moore Capital Management, LP | 97,273 | $107.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 57,800 | $63.6K | 0.00% | −6,802−10.5% | Reduced |
| Revisor Wealth Management LLC | 41,348 | $45.5K | 0.01% | +29,466+248.0% | Added |
| Virtu Financial LLC | 22,485 | $25.0K | 0.00% | +3,540+18.7% | Added |
| BlackRock, Inc. | 20,500 | $22.6K | 0.00% | −2,490−10.8% | Reduced |
| Geode Capital Management, LLC | 20,357 | $22.4K | 0.00% | −2,182−9.7% | Reduced |
| Atria Investments LLC | 11,957 | $13.2K | 0.00% | +11,957 | New |
| Quent Capital, LLC | 10,321 | $11.4K | 0.00% | 00.0% | Unchanged |